Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study

Abstract INTRODUCTION Polypharmacy is common in older adults with mild cognitive impairment (MCI), but its impact on cognitive decline is unclear. Studies on the association between polypharmacy and cognitive outcomes have yielded inconsistent evidence. The objective of this study was to assess the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ying‐Hsin Hsu, Chih‐Kuang Liang, Ming‐Yueh Chou, Hsiu‐Chu Shen, Yu‐Chun Wang, Hirotaka Iwaki, Yu‐Te Lin, Yang C. Fann
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-10-01
Colecção:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Assuntos:	aging cognitive decline dementia mild cognitive impairment polypharmacy
Acesso em linha:	https://doi.org/10.1002/trc2.70179
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!